Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitor add-on therapy is a new option for patients with inadequately controlled type 2 diabetes who are taking combined metformin and sulfonylurea (SU). We evaluated the efficacy and safety of this triple therapy and the characteristics of rapid responde...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ye An, Yoo, Won Sang, Hong, Eun Shil, Ku, Eu Jeong, Park, Kyeong Seon, Lim, Soo, Cho, Young Min, Park, Kyong Soo, Jang, Hak Chul, Choi, Sung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696985/
https://www.ncbi.nlm.nih.gov/pubmed/26616595
http://dx.doi.org/10.4093/dmj.2015.39.6.489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696985/
https://www.ncbi.nlm.nih.gov/pubmed/26616595
http://dx.doi.org/10.4093/dmj.2015.39.6.489

Ejemplares similares